Cargando…

Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system

The study reported here aimed to develop an optimized nanoparticle delivery system for amphotericin B (AmpB) using a polyelectrolyte complexation technique. For this, two oppositely charged polymers presenting anti-leishmanial activity – chitosan (Cs) and chondroitin sulfate (ChS) – were used: Cs as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Tatiana G, Chávez-Fumagalli, Miguel A, Valadares, Diogo G, França, Juçara R, Rodrigues, Lívia B, Duarte, Mariana C, Lage, Paula S, Andrade, Pedro H R, Lage, Daniela P, Arruda, Leonardo V, Abánades, Daniel R, Costa, Lourena E, Martins, Vivian T, Tavares, Carlos AP, Castilho, Rachel O, Coelho, Eduardo AF, Faraco, André AG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931713/
https://www.ncbi.nlm.nih.gov/pubmed/24627630
http://dx.doi.org/10.2147/IJN.S55678
_version_ 1782304701981655040
author Ribeiro, Tatiana G
Chávez-Fumagalli, Miguel A
Valadares, Diogo G
França, Juçara R
Rodrigues, Lívia B
Duarte, Mariana C
Lage, Paula S
Andrade, Pedro H R
Lage, Daniela P
Arruda, Leonardo V
Abánades, Daniel R
Costa, Lourena E
Martins, Vivian T
Tavares, Carlos AP
Castilho, Rachel O
Coelho, Eduardo AF
Faraco, André AG
author_facet Ribeiro, Tatiana G
Chávez-Fumagalli, Miguel A
Valadares, Diogo G
França, Juçara R
Rodrigues, Lívia B
Duarte, Mariana C
Lage, Paula S
Andrade, Pedro H R
Lage, Daniela P
Arruda, Leonardo V
Abánades, Daniel R
Costa, Lourena E
Martins, Vivian T
Tavares, Carlos AP
Castilho, Rachel O
Coelho, Eduardo AF
Faraco, André AG
author_sort Ribeiro, Tatiana G
collection PubMed
description The study reported here aimed to develop an optimized nanoparticle delivery system for amphotericin B (AmpB) using a polyelectrolyte complexation technique. For this, two oppositely charged polymers presenting anti-leishmanial activity – chitosan (Cs) and chondroitin sulfate (ChS) – were used: Cs as a positively charged polymer and ChS as a negatively charged polymer. The chitosan (NQ) nanoparticles, chitosan-chondroitin sulfate (NQC) nanoparticles, and chitosan-chondroitin sulfate-amphotericin B (NQC-AmpB) nanoparticles presented a mean particle size of 79, 104, and 136 nm, respectively; and a polydispersity index of 0.2. The measured zeta potential of the nanoparticles indicated a positive charge in their surface, while scanning and transmission electron microscopy revealed spherical nanoparticles with a smooth surface. Attenuated total reflectance-Fourier transform infrared spectroscopy analysis showed an electrostatic interaction between the polymers, whereas the release profile of AmpB from the NQC-AmpB nanoparticles showed a controlled release. In addition, the Cs; ChS; and NQ, NQC, and NQC-AmpB nanoparticles proved to be effective against promastigotes of Leishmania amazonensis and Leishmania chagasi, with a synergistic effect observed between Cs and ChS. Moreover, the applied NQ, NQC, and NQC-AmpB compounds demonstrated low toxicity in murine macrophages, as well as null hemolytic activity in type O(+) human red blood cells. Pure AmpB demonstrated high toxicity in the macrophages. The results show that cells infected with L. amazonensis and later treated with Cs, ChS, NQ, NQC, NQC-AmpB nanoparticles, or pure AmpB presented with a significant reduction in parasite number in the order of 24%, 31%, 55%, 66%, 90%, and 89%, respectively. The data presented indicate that the engineered NQC-AmpB nanoparticles could potentially be used as an alternative therapy to treat leishmaniasis, mainly due its low toxicity to mammals’ cells.
format Online
Article
Text
id pubmed-3931713
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-39317132014-03-13 Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system Ribeiro, Tatiana G Chávez-Fumagalli, Miguel A Valadares, Diogo G França, Juçara R Rodrigues, Lívia B Duarte, Mariana C Lage, Paula S Andrade, Pedro H R Lage, Daniela P Arruda, Leonardo V Abánades, Daniel R Costa, Lourena E Martins, Vivian T Tavares, Carlos AP Castilho, Rachel O Coelho, Eduardo AF Faraco, André AG Int J Nanomedicine Original Research The study reported here aimed to develop an optimized nanoparticle delivery system for amphotericin B (AmpB) using a polyelectrolyte complexation technique. For this, two oppositely charged polymers presenting anti-leishmanial activity – chitosan (Cs) and chondroitin sulfate (ChS) – were used: Cs as a positively charged polymer and ChS as a negatively charged polymer. The chitosan (NQ) nanoparticles, chitosan-chondroitin sulfate (NQC) nanoparticles, and chitosan-chondroitin sulfate-amphotericin B (NQC-AmpB) nanoparticles presented a mean particle size of 79, 104, and 136 nm, respectively; and a polydispersity index of 0.2. The measured zeta potential of the nanoparticles indicated a positive charge in their surface, while scanning and transmission electron microscopy revealed spherical nanoparticles with a smooth surface. Attenuated total reflectance-Fourier transform infrared spectroscopy analysis showed an electrostatic interaction between the polymers, whereas the release profile of AmpB from the NQC-AmpB nanoparticles showed a controlled release. In addition, the Cs; ChS; and NQ, NQC, and NQC-AmpB nanoparticles proved to be effective against promastigotes of Leishmania amazonensis and Leishmania chagasi, with a synergistic effect observed between Cs and ChS. Moreover, the applied NQ, NQC, and NQC-AmpB compounds demonstrated low toxicity in murine macrophages, as well as null hemolytic activity in type O(+) human red blood cells. Pure AmpB demonstrated high toxicity in the macrophages. The results show that cells infected with L. amazonensis and later treated with Cs, ChS, NQ, NQC, NQC-AmpB nanoparticles, or pure AmpB presented with a significant reduction in parasite number in the order of 24%, 31%, 55%, 66%, 90%, and 89%, respectively. The data presented indicate that the engineered NQC-AmpB nanoparticles could potentially be used as an alternative therapy to treat leishmaniasis, mainly due its low toxicity to mammals’ cells. Dove Medical Press 2014-02-14 /pmc/articles/PMC3931713/ /pubmed/24627630 http://dx.doi.org/10.2147/IJN.S55678 Text en © 2014 Ribeiro et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Ribeiro, Tatiana G
Chávez-Fumagalli, Miguel A
Valadares, Diogo G
França, Juçara R
Rodrigues, Lívia B
Duarte, Mariana C
Lage, Paula S
Andrade, Pedro H R
Lage, Daniela P
Arruda, Leonardo V
Abánades, Daniel R
Costa, Lourena E
Martins, Vivian T
Tavares, Carlos AP
Castilho, Rachel O
Coelho, Eduardo AF
Faraco, André AG
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system
title Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system
title_full Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system
title_fullStr Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system
title_full_unstemmed Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system
title_short Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system
title_sort novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931713/
https://www.ncbi.nlm.nih.gov/pubmed/24627630
http://dx.doi.org/10.2147/IJN.S55678
work_keys_str_mv AT ribeirotatianag noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT chavezfumagallimiguela noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT valadaresdiogog noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT francajucarar noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT rodriguesliviab noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT duartemarianac noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT lagepaulas noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT andradepedrohr noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT lagedanielap noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT arrudaleonardov noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT abanadesdanielr noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT costalourenae noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT martinsviviant noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT tavarescarlosap noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT castilhorachelo noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT coelhoeduardoaf noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem
AT faracoandreag noveltargetingusingnanoparticlesanapproachtothedevelopmentofaneffectiveantileishmanialdrugdeliverysystem